Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
|
|
Oncternal Therapeutics, Inc. (GTXI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Disposed/sold 65,000 options
@ $6.46, valued at
$419.9k
Disposed/sold 55,519 options
@ $1.94, valued at
$107.7k
Disposed/sold 28,750 options
@ $1.04, valued at
$29.9k
Disposed/sold 210,000 options
@ $0.96, valued at
$201.6k
Granted 65,000 options
@ $0
Granted 55,519 options
@ $0
Granted 28,750 options
@ $0
Granted 210,000 options
@ $0
Granted 235,000 options
@ $0.31, valued at
$72.9k
|
|
| 10/04/2023 |
4
| Yazji Salim (Chief Medical Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Disposed/sold 354,400 options
@ $5.3, valued at
$1.9M
Disposed/sold 92,075 options
@ $1.94, valued at
$178.6k
Disposed/sold 55,000 options
@ $1.04, valued at
$57.2k
Disposed/sold 210,000 options
@ $0.96, valued at
$201.6k
Granted 354,400 options
@ $0
Granted 92,075 options
@ $0
Granted 55,000 options
@ $0
Granted 210,000 options
@ $0
Granted 70,600 options
@ $0.31, valued at
$21.9k
|
|
| 10/04/2023 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Disposed/sold 100,000 options
@ $5.76, valued at
$576k
Disposed/sold 66,890 options
@ $3.33, valued at
$222.7k
Disposed/sold 750,000 options
@ $7.05, valued at
$5.3M
Disposed/sold 637,000 options
@ $1.94, valued at
$1.2M
Disposed/sold 123,750 options
@ $1.04, valued at
$128.7k
Disposed/sold 650,000 options
@ $0.96, valued at
$624k
Granted 100,000 options
@ $0
Granted 66,890 options
@ $0
Granted 750,000 options
@ $0
Granted 637,000 options
@ $0
Granted 123,750 options
@ $0 |
|
| 10/04/2023 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Disposed/sold 75,000 options
@ $5.76, valued at
$432k
Disposed/sold 35,120 options
@ $3.33, valued at
$116.9k
Disposed/sold 280,000 options
@ $7.05, valued at
$2M
Disposed/sold 109,579 options
@ $1.94, valued at
$212.6k
Disposed/sold 28,750 options
@ $1.04, valued at
$29.9k
Disposed/sold 210,000 options
@ $0.96, valued at
$201.6k
Granted 75,000 options
@ $0
Granted 35,120 options
@ $0
Granted 280,000 options
@ $0
Granted 109,597 options
@ $0
Granted 28,750 options
@ $0 |
|
| 10/04/2023 |
4
| Krishnan Rajesh (Chief Technical Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Disposed/sold 75,000 options
@ $4.3, valued at
$322.5k
Disposed/sold 40,000 options
@ $5.76, valued at
$230.4k
Disposed/sold 12,470 options
@ $3.33, valued at
$41.5k
Disposed/sold 160,000 options
@ $4.59, valued at
$734.4k
Disposed/sold 177,050 options
@ $1.94, valued at
$343.5k
Disposed/sold 28,750 options
@ $1.04, valued at
$29.9k
Disposed/sold 220,000 options
@ $0.96, valued at
$211.2k
Granted 75,000 options
@ $0
Granted 40,000 options
@ $0
Granted 12,470 options
@ $0
Granted 160,000 options
@ $0 |
|
| 07/05/2023 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 47,992 shares
@ $0.36, valued at
$17.3k
Paid exercise price by delivering 4,007 shares
@ $0.36, valued at
$1.4k
|
|
| 07/05/2023 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 10,305 shares
@ $0.36, valued at
$3.7k
|
|
| 07/05/2023 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 7,069 shares
@ $0.36, valued at
$2.5k
|
|
| 07/05/2023 |
4
| Yazji Salim (Chief Medical Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 16,299 shares
@ $0.36, valued at
$5.9k
|
|
| 07/05/2023 |
4
| Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 10,897 shares
@ $0.36, valued at
$3.9k
|
|
| 06/30/2023 |
4
| THEUER CHARLES (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 06/30/2023 |
4
| CARTER MICHAEL G (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 06/30/2023 |
4
| LARUE WILLIAM R (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 06/30/2023 |
4
| Wills Robert James (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 06/30/2023 |
4
| MAZANET ROSEMARY (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 06/30/2023 |
4
| Nakanishi Xin (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 06/30/2023 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 06/30/2023 |
4
| HALE DAVID F (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 37,500 options
@ $0.3553, valued at
$13.3k
|
|
| 06/30/2023 |
4
| DeSimone Jill (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2023 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 650,000 options
@ $0.96, valued at
$624k
Granted 65,000 options
@ $0.96, valued at
$62.4k
Granted 42,196 options
@ $0.81, valued at
$34.2k
|
|
| 02/23/2023 |
4
| Yazji Salim (Chief Medical Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 210,000 options
@ $0.96, valued at
$201.6k
|
|
| 02/23/2023 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 210,000 options
@ $0.96, valued at
$201.6k
|
|
| 02/23/2023 |
4
| Kaufmann Gunnar F. (Chief Scientific Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 210,000 options
@ $0.96, valued at
$201.6k
|
|
| 02/23/2023 |
4
| Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 220,000 options
@ $0.96, valued at
$211.2k
|
|
| 02/23/2023 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 210,000 options
@ $0.96, valued at
$201.6k
|
|
| 01/05/2023 |
4
| DeSimone Jill (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 50,000 options
@ $1.04, valued at
$52k
|
|
| 01/05/2023 |
4
| Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,238 shares
@ $1.02, valued at
$6.4k
|
|
| 01/05/2023 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 27,793 shares
@ $1.02, valued at
$28.3k
Paid exercise price by delivering 1,325 shares
@ $1.02, valued at
$1.4k
|
|
| 01/05/2023 |
4
| Leavitt Chase C. (General Counsel/Secretary) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,091 shares
@ $1.02, valued at
$6.2k
|
|
| 01/05/2023 |
4
| Kaufmann Gunnar F. (Chief Scientific Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,266 shares
@ $1.02, valued at
$6.4k
|
|
|
|
|